Can you summarize the current evidence for amikacin liposome inhaled suspension, the patients in which it is appropriately deployed, and what supportive and educational measures improve toleration, adherence and durability of long-term treatment?
Can you summarize the current evidence for amikacin liposome inhaled suspension, the patients in which it is appropriately deployed, and what supportive and educational measures improve toleration, adherence and durability of long-term treatment?
Created by
Presenter
Associate Professor of Medicine
Department of Medicine
Division of Mycobacterial & Respiratory Infections
National Jewish
Denver, Colorado